Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Motor Activity × Ipilimumab × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 11 Neoplasms 4 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 1 Recurrent Squamous Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Motor Activity 1 Kidney Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

Exercise 14 Surveys and Questionnaires 8 Walking 2 Physical Examination 2 Interviews as Topic 2 Diet 2 pembrolizumab 1 methyl hydroxyethyl cellulose 1 Waiting Lists 1 Thoracotomy 1 Nivolumab 1 Masks 1 Lead 1 Karnofsky Performance Status 1 Ipilimumab 1 Immunotherapy 1 Hand Strength 1 Gastrectomy 1 Focus Groups 1 Fitness Trackers 1 Esophagectomy 1 Early Ambulation 1 Drug Therapy 1 Counseling 1 Blood Pressure Monitoring, Ambulatory 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06627595 2024-11-15

APiTOXMM

University Hospital, Montpellier

Melanoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡